Trials / Completed
CompletedNCT01755000
Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings
A Pilot Feasibility Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test how practical it is to use the Ultrasonic Cardiac Output Monitor (USCOM), an FDA-approved device, on oncology patients (specifically those with blood cancers). Additionally, the researchers will learn if the USCOM gives additional information about patients' conditions when their blood pressures drop and they are treated with intravenous fluids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | USCOM scan | |
| PROCEDURE | Fluid Bolus |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2012-12-21
- Last updated
- 2013-09-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01755000. Inclusion in this directory is not an endorsement.